Description: Predictive Analytics and Epigenetics are two of the most impactful driving forces for the future of healthcare, precision medicine, and insurance. Learn why this is true, how if will change the way our industry operates, and how you can stay viable and contribute to the betterment of humanity while also protecting the actuarial profession from obsolescence. Learn how personalized medicine keying off genetic testing is saving life insurers big dollars. The only limit seems to be testing access for their insureds.

Description: This article, an Honorable Mention Essay for the Society of Actuaries' Entrepreneurial Actuaries Section 2010 Papers Competition, is a discussion of the various issues relating to measurement of data in healthcare. The author presents “a light hearted & tongue-in-cheek take on how healthcare is typically measured, and an entrepreneurial vision for a better world.” Noting that typically data is summarized in deterministic models that produce point estimates for analysis and decision making, the author’s vision presented in the paper “is that of a central repository of actuarially modeled distributions that can either be used as benchmarks or adapted to an organization's experience.”

Description: Critical illness CI products are gaining in popularity in North America. These products have been available for close to 20 years in many countries around the world, including South Africa, Australia, the United Kingdom and most of Asia. Many of the lessons learned in these countries concerning product design, pricing, underwriting and claims adjudication are relevant to the U.S. market. This session reviews the latest trends around the world. Attendees gain insight into the key issues driving the profitability of the product and are better positioned to determine the main considerations in deciding whether or not to introduce such a product in their market. From the Record of the Society of Actuaries, Volume 29, No. 1, Washington, D.C., Spring Meeting, May 29–30, 2003, Session 60PD.

Description: This presentation from Session 100PD of the SOA 1999 San Francisco Annual Meeting is about the evolution of medical underwriting: where we've been, what we've learned, where we are, and where we go from here. The panelists also discuss the role and purpose of underwriting in the individual market, how societal attitudes have changed, and the resulting legislative challenges to industry practices. Specific states with 'innovative' requirements [New York and Florida, for example] and the resulting impact on the health care markets in those states are reviewed. Current topics include proposed limits on HIV testing, genetic testing, issues surrounding privacy and confidentiality, the impact of guaranteed issue, and community rating in the marketplace. From the Record of the Society of Actuaries, Vol. 25, No. 3.

Description: This is a discussion about the Opinion No. 8 Bulletin on accounting for the cost of pension plans that was recently issued by the Accounting Principles Board of the American Institute of Certified Public Accountants and the effect this bulletin will have on the preparation of actuarial valuations of pension plans. Also discussed is the use of level-premium life insurance in connection with employee benefit plans and the underwriting, actuarial and other problems encountered in the design and marketing of such plans. Finally, the discussion moves to the marketing, underwriting and administration of vision care and prescription drug benefits, and the advantages and disadvantages of providing survivor benefits in group life and qualified pension plans. From Transactions of Society of Actuaries 1967, Vol. 19 Pt. 2, No. 53.

Description: From the April 1982 Society of Actuaries meeting in Houston. Discussion of how the insurance industries in several countries have dealt with high levels of inflation with respect to the development and marketing of insurance products. Also discussed: I. the overall business and economic environment 2. the taxation structure of insurance companies 3. the availability of suitable investments 4. the insurance regulatory climate and 5. the structure of worldwide capital markets Possible applications to U.S. insurance in the 1980's were explored.

Description: September 2009 issue of the Reinsurance Section newsletter

Description: This session from the 1984 SOA New York City Meeing describes the venture capital fund life cycle, the risks, benefits, returns and approaches to investing in venture capital companies, leveraged buyouts and the practicalities for insurance company investing. From Record of the Society of Actuaries Vol. 10, No. 3

Description: This session is about actuaries' relationships with, and independence from, lawyers and accountants.

Description: View the Spring 2021 General Insurance - Financial And Regulatory Environment – U.S. Exam Case Study.